Pulse Biosciences, Inc. (PLSE), a bioelectric medicine company, Thursday, announced the appointment of Liane Teplitsky as Chief Operating Officer.
Further, the company said that it has expanded the role of David Kenigsberg as full-time Chief Medical Officer.
Teplitsky brings twenty years of experience leading and scaling innovative medical technology businesses and was most recently the Chief Executive of Artedrone. Prior to this role, she held senior marketing and commercial leadership roles at Abbott Laboratories and St. Jude Medical.
In pre-market activity, PLSE shares were trading at $19, down 0.31% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.